LSI (Life Science Innovations Fund)
VC Fund
Bialystok, Poland
LSI (Life Science Innovations Fund) is a VC fund in Bialystok focused on Health Care and Life Science. LSI is a pre-seed and seed stage venture capital in Poland. We invest in early-stage start ups in life science domain. We mainly focus on healthcare, environmental protection, biotech and medtech. We are a team of passionate people whose goal is to improve everyone’s life and make the world a better place.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries LSI (Life Science Innovations Fund) invests in
Health CareLife ScienceMedical DevicePersonal HealthHealth Diagnostics
Stages LSI (Life Science Innovations Fund) invests in
Pre-SeedSeedGrantSeries D
Countries LSI (Life Science Innovations Fund) invests in
PolandUnited States
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Investment Focus
Industry
- Health Care 3 (27%)
- Life Science 3 (27%)
- Medical Device 3 (27%)
- Personal Health 2 (18%)
- Health Diagnostics 2 (18%)
Stage
- Pre-Seed 5 (45%)
- Seed 4 (36%)
- Grant 1 (9%)
- Series D 1 (9%)
Country
- Poland 9 (82%)
- United States 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Paweł Wilski
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TMRW Life Sciences
|
TMRW is a life sciences technology company setting new standards for transparency, safety, and accountability in IVF and cell management. TMRW's platform, the world's first automated cryo-management for eggs and embryos, provides a complete digital chain of custody fully integrated with a robotic storage and monitoring solution. This isin contrast to the manual and analog methods that have gone unchanged throughout the history of IVF. With TMRW's platform, clinics significantly reduce the chances of potentially devastating errors. The TMRW team includes celebrated innovators in fertility, embryology, cryo-management, automation, software development, and robotics. TMRW is founded by Joshua Abram, Alan Murray, and Dr. Jeffrey Port in 2018 and is based in New York, New York. | $28.2M / Series D / Jul 12, 2024 | |
Health2Organ
|
Health2Organ is a manufacturer and provider of adhesives and medical devices for process of transplantology. | Seed / Jan 01, 2022 | |
Hagi Cosmetics
|
Hagi Cosmetics is a natural cosmetics brand. The company is a family business run by a mother – chemist/cosmetologist along with her daughters. All products are manufactured using traditional methods and conform with the requirements of natural and organic cosmetic certification companies. Our wide range of products includes face care, bodycare, bath and baby products. | $206.4K / Grant / Dec 02, 2021 | |
|
Health 2 Organ
|
Health 2 Organ is a team of meditians and engineers that aspire to invent a medical device that will be used in transplantology. We aspire to develop a device that uses constant perfusion & nanothermia to keep organs (kidneys) ex vivo. This system allows to keep the organs longer and in better quality. It would also enable healing organs. | Pre-Seed / Jul 04, 2020 | |
ABA Stroke
|
ABAStroke is the MedTech company developing digital therapeutics for patients after stroke requiring long-term neuropsychological rehabilitation.The innovation of ABAStroke is based on three principles:1. The core of the product is based on Applied Behavior Analysis (ABA) which is the leading, research-based methodology proven to bringmeaningful change in behavior in individuals with cognitive impairments. 2. The system is dynamically adapting to patients' needs with machine learning algorithms. 3. It is dedicated to home rehabilitation and designed for mobile devices, so patients can experience effective therapy at any place and time, without the presence of a specialist, to a greater extent than the traditional health system offers them. The health systems in many EU countries can provide reasonably good health services, but usually only at the beginning during primary rehabilitation. The huge gap in care occurs when patients return home. Lack of neuropsychologists makes further rehabilitation very limited to private treatment. The aging population leads to a higher number of strokes and the problem will be more concerning in the coming years. Urgent action is needed, and we strongly believe that ABAStroke, the well crafted DTx based on ABA, is the right solution to face the challenge. | Pre-Seed / Dec 13, 2019 | |
MeWheel
|
MeWheel is an innovative wheelchair drive, revolutionizing the existing market - the solution is cheap, light, discreet and attractive for end users. Thanks to technical simplicity we have a significant cost advantage over the competition, while providing high functionality. We can replace almost any manual trolley with an electric one, withoutsignificantly affecting its appearance,weight or folding options.We work hard so that everyone can feel the wind in their hair! | Pre-Seed / Aug 08, 2019 | |
BrainScan
|
BrainScan is a MedTech startup, that has developed A.I. powered brain scans interpretation solution for digital imaging diagnostics as Computed Tomography to prevent under-reporting problem and prioritizing patients using Augmented Intelligence, by detecting up to 26 brain lesions.We have secured large & tagged brain CT database (datasetcover 250K CT exams with text reports) to develop high quality neural networks architecture for autonomous brain scans interpretation. Clinical Evaluation (POC) was introduced in October 2020.Since 2019, BrainScan CT - decision support system for the interpretation of head computed tomography based on machine learning is a medical product labeling the CE2274 mark.BrainScan company develope a high quality product, as evidenced by received certificates confirming compliance with the requirements of the ISO13485: 2016 standard and the requirements of the MDD 93/42 / EEC Directive. In 2023, we obtained CE MDR 2017/ 745 medical certification, product class IIa. | $250K / Seed / Apr 10, 2019 | |
Wheelstair
|
75 Million wheelchair users and no adequate stair climbing devices. Worldwide there are about 75 million wheelchair users but no adequate stair climbing devices. Available devices are expensive, with a short operation time, poor compatibility, no manual mode or require assistance from a third person. For the first time Wheelstair offers a devicesolution that meets the requirements of many wheelchair users. It is affordable, easy to use and allows a real independent management of stair climbing. Wheelstair is compatible with most wheelchairs, easy to use and its versatile functions and appealing design enjoys its users. | Pre-Seed / Apr 26, 2018 | |
Lumisep
|
LumiSep was registered in April 2015. Its establishment was the result of innovative work of a group of Polish scientists who saw the possibility of detecting and accurately measuring trace amounts of harmful substances such as mycotoxins, polycyclic aromatic hydrocarbons, heavy metals and antibiotics in food and the environment using uniquetechnology. The cooperation resulted in the creation of the first device allowing for high sensitivity detection at the level of part per billion (ppb). The analyzed mixtures of harmful substances are determined by means of a unique technology without the need to separate them into individual components. In addition to the development of new measurement techniques, LumiSep also has the specific know-how and equipment to produce high-end chromatographic columns for High Performance Liquid Chromatography (HPLC) and its UPLC version. | Pre-Seed / Mar 28, 2018 | |
Bioseco
|
Bioseco developed the Multirejestrator - highly innovative system that monitors and protects birds from colliding with wind farms and prevents birdstrikes at the airports.Bioseco is a team of IT engineers, optical, radar and computer specialists who work closely with ornithologists, chiropterologists, aviation experts and high securityinstallation specialists to develop, refine and optimise an innovative and cost-effective system that protects birds and reduce costs at the airports (during takeoff and landing, thereby increasing air passenger safety and reducing aircraft repair costs and bird mortality) and wind farms.Bioseco co-operates with institutions like Instytut Morski (Marine Institute) in Gdańsk, Pomorski Park Naukowo-Technologiczny in Gdynia, Technopark Gliwice, Krakowski Park Technologiczny and ornithological organizations.The company's goal is to create devices and tools for authoritative research of environment, with a wide practical application. | Seed / Apr 06, 2016 | |
| See all 11 investments → | |||
Co-Investors
5AM Ventures
1 deal together
Casdin Capital
1 deal together
DF Capital
1 deal together
DF Investment Partners
1 deal together
FIOS Venture Holdings
1 deal together
Google Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Medical Device Investors
11,047 investors
Life Science Investors
6,823 investors
Health Care VC Funds
32,370 investors
Biotech VC Funds
18,864 investors
Medical Device VC Funds
9,894 investors
Life Science VC Funds
6,096 investors
Health Care Investors in United States
21,541 investors
FAQ
What does LSI (Life Science Innovations Fund) invest in?
LSI (Life Science Innovations Fund) invests primarily in Health Care, Life Science and Medical Device startups, most often at Pre-Seed and Seed stage. Most of the 11 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact LSI (Life Science Innovations Fund)?
Public channels for LSI (Life Science Innovations Fund) include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at LSI (Life Science Innovations Fund)?
The team at LSI (Life Science Innovations Fund) includes Paweł Wilski (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
